Vericel Corp SEC filings VCEL
Vericel Corp has 1,002 filings in SEC EDGAR's recent list, going back to Aug 7, 2013. Its latest annual report, Form ARS, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| CT ORDER | Filing | Jan 19, 2022 | — |
| 8-A12B/A | Filing | Feb 12, 2021 | — |
| SEC STAFF LETTER | Filing | Nov 19, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2019 | — |
| CORRESP | Letter to the SEC | Nov 13, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 5, 2019 | — |
| SEC STAFF LETTER | Filing | Nov 4, 2019 | — |
| CT ORDER | Filing | Nov 28, 2018 | — |
| EFFECT | Filing | Aug 28, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2018 | — |
| CORRESP | Letter to the SEC | Aug 24, 2018 | — |
| CT ORDER | Filing | Jun 6, 2018 | — |
| CT ORDER | Filing | Apr 6, 2018 | — |
| CT ORDER | Filing | Jan 11, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2017 | — |
| CT ORDER | Filing | Nov 14, 2017 | — |
| CORRESP | Letter to the SEC | Oct 18, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 5, 2017 | — |
| CORRESP | Letter to the SEC | Sep 11, 2017 | — |
| CT ORDER | Filing | Aug 14, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2017 | — |
| CT ORDER | Filing | Aug 10, 2017 | — |
| CT ORDER | Filing | Jul 11, 2017 | — |
| CT ORDER | Filing | Jan 30, 2017 | — |
| CT ORDER | Filing | Jan 26, 2017 | — |
| CT ORDER | Filing | Jan 4, 2017 | — |
| CT ORDER | Filing | Dec 19, 2016 | — |
| CT ORDER | Filing | Nov 3, 2016 | — |
| CT ORDER | Filing | Jul 1, 2016 | — |
| CT ORDER | Filing | Dec 14, 2015 | — |
| EFFECT | Filing | Jul 15, 2015 | — |
| EFFECT | Filing | Jul 15, 2015 | — |
| EFFECT | Filing | Jul 15, 2015 | — |
| EFFECT | Filing | Jul 15, 2015 | — |
| CORRESP | Letter to the SEC | Jul 13, 2015 | — |
| CORRESP | Letter to the SEC | Jul 13, 2015 | — |
| CORRESP | Letter to the SEC | Jul 13, 2015 | — |
| CORRESP | Letter to the SEC | Jul 13, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2015 | — |
| EFFECT | Filing | Sep 10, 2014 | — |
| EFFECT | Filing | Apr 3, 2014 | — |
| CORRESP | Letter to the SEC | Apr 2, 2014 | — |
| UPLOAD | Letter from the SEC | Feb 24, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2013 | — |
| CORRESP | Letter to the SEC | Sep 5, 2013 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2013 | — |
| POS EX | Post-effective amendment not automatically effective upon filing | Aug 14, 2013 | — |
| EFFECT | Filing | Aug 13, 2013 | — |
Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VCEL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MI
- Headquarters
- Burlington, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 887359
- Former names
- AASTROM BIOSCIENCES INC (until Nov 14, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.